Second Generation Drug-Eluting Stent Implantation versus Coronary Artery Bypass Grafting in the Treatment of Young Patients with Left Main and/or Multivessel Coronary Disease

Table 2

Clinical outcome of overall patients before adjustment by propensity score matching.

	PCI (n = 132)	CABG (n = 81)	Unadjusted HR (95% CI)	-value	Adjusted HR (95% CI)	-value
MACCE	27 (20.5%)	7 (8.6%)	2.508 (1.091, 5.762)	0.030	3.263 (1.379, 7.722)	0.007
MI	2 (1.5%)	2 (2.5%)	0.601 (0.085, 4.268)	0.611	1.222 (0.132, 11.271)	0.860
Stroke	0	2 (2.5%)	0.008 (0.00, 1535.874)	0.435	0 (0.00, 1.490E + 048)	0.881
Death	0	2 (2.5%)	0.008 (0.00, 1423.967)	0.436	0 (0.00, 7.074E + 143)	0.939
Repeat revascularization	25 (18.9%)	3 (3.7%)	5.435 (1.640, 18.011)	0.006	6.968 (2.036, 23.842)	0.002

CABG: coronary artery bypass grafting; CI: confidence interval; HR: hazard ratio; MACCE: major adverse cardiovascular or cerebrovascular events which is the composite of all-cause death, stroke, MI or repeat revascularization; MI: myocardial infarction; PCI: percutaneous coronary intervention.